SS

Suryansu Sekhar Mahapatra

Active Director Managing Director DIN 09170948
DIN 09170948 First appointment May 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Suryansu Sekhar Mahapatra

Data last updated:

Suryansu Sekhar Mahapatra is a Managing Director at Three's Drug Solution Private Limited (since 2021). The company operates in Chemicals.

DIN 09170948
Primary Designation Managing Director
Industry Chemicals
First Appointment 12 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director12 May 20212021Active

Board colleagues of Suryansu Sekhar Mahapatra

Directorship timeline

Open interactive timeline →
Three's Drug Solution Private Limited
Premium access

Shareholding and investment profile for Suryansu Sekhar Mahapatra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suryansu Sekhar Mahapatra

Suryansu Sekhar Mahapatra currently holds 1 directorship: Three's Drug Solution Private Limited (Managing Director, since 12 May 2021).

Suryansu Sekhar Mahapatra was first appointed on 12 May 2021 as Managing Director at Three's Drug Solution Private Limited.

The current boards of Suryansu Sekhar Mahapatra's companies include Nacalparty Nageswar Rao (Three's Drug Solution Private Limited), Sujit Narayan Barik (Three's Drug Solution Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available